60 Degrees Pharmaceutical... (SXTP)
NASDAQ: SXTP
· Real-Time Price · USD
1.40
-0.04 (-2.64%)
At close: Oct 03, 2025, 3:59 PM
1.42
1.43%
After-hours: Oct 03, 2025, 04:38 PM EDT
60 Degrees Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -4.21M | -10.26M | -7.95M | -7.86M | -1.53M | -697.69K | -3.73M | -3.69M | -9.31M | -8.12M | -6.43M | -5.87M | -4.42M | -2.27M | -1.36M |
Depreciation & Amortization | 30.61K | 58.41K | 63.74K | 71.24K | 82.02K | 96K | 100.37K | 98.34K | 92.34K | 86.47K | 78.79K | 75.76K | 56.33K | 37.2K | 18.38K |
Stock-Based Compensation | 730.61K | 792.01K | 730.61K | 1.52M | 1.25M | 1.65M | 2.06M | 1.21M | 812.01K | 533.43K | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 66.79K | 27.47K | -76.68K | 855.46K | -674.09K | -167.3K | 592.72K | 381.08K | 3M | 3.24M | 3.04M | 3.01M | 2.18M | 1.34M | 735.65K |
Other Non-Cash Items | -3M | 3.05M | 1.32M | 1.48M | 1.45M | 678.43K | 3.3M | 3.71M | 4.11M | 2.76M | 2.03M | 1.59M | 1.16M | 398.05K | 241.52K |
Deferred Income Tax | n/a | n/a | n/a | -565.76K | -6.41M | -6.41M | -6.41M | -5.84M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 82.48K | 257.66K | 192.72K | 1.28M | -983.85K | -317.57K | 405.36K | 245.83K | 3.47M | 3.42M | 3.31M | 2.95M | 2.26M | 1.42M | 793.63K |
Operating Cash Flow | -6.37M | -6.11M | -5.65M | -4.07M | -6.15M | -5.27M | -4.54M | -4.55M | -1.1M | -1.32M | -1.01M | -1.26M | -948.41K | -414.02K | -311.46K |
Capital Expenditures | -40.74K | -176.78K | -181.11K | -245.58K | -234.84K | -122.41K | -115.89K | -107.97K | -80.06K | -64.02K | -61.55K | -4.66K | -4.66K | -2.58K | -1.75K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 1.71M | 1.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.73M | -1.73M | -1.73M | -1.74M | -36.85K | -36.85K | -36.85K | -26.08K | 1.42K | 1.42K | 1.42K | 1.42K | n/a | n/a | n/a |
Investing Cash Flow | -97.91K | -176.78K | -1.89M | -1.95M | -234.84K | -122.41K | -115.89K | -107.97K | -78.64K | -62.6K | -60.13K | -3.24K | -4.66K | -2.58K | -1.75K |
Debt Repayment | n/a | n/a | n/a | n/a | -1.61M | -1.61M | -1.61M | -1.61M | n/a | n/a | n/a | 83.84K | 83.84K | 83.84K | 83.84K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -185.34K | -185.34K | -185.34K | -185.34K | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 23.05K | 23.05K | 11.83K | 59.2K | 1.27M | 1.59M | 1.78M | 1.56M | -316.62K | 652.64K | 470.26K | 538.88K | 1.29M | n/a | n/a |
Financial Cash Flow | 6.85M | 6.85M | 7.05M | 7.05M | 7.87M | 8.2M | 6.47M | 6.41M | -316.62K | 652.64K | 470.26K | 622.73K | 1.37M | 83.84K | 83.84K |
Net Cash Flow | 390.33K | 556.8K | -483.13K | 1.08M | 1.56M | 2.86M | 1.88M | 1.78M | -1.48M | -830.03K | -601.98K | -647.61K | 415.9K | -226.98K | -220.15K |
Free Cash Flow | -3.36M | -6.28M | -5.83M | -4.32M | -6.38M | -5.39M | -4.66M | -4.65M | -1.18M | -1.38M | -1.07M | -1.26M | -953.07K | -416.6K | -313.22K |